Citizens (CIA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
The 2026 Annual Meeting is scheduled for June 16, 2026, at the company’s Austin, Texas headquarters, with a record date of April 17, 2026.
Four main proposals will be voted on: election of seven directors, ratification of Grant Thornton LLP as auditor, advisory approval of executive compensation, and approval of the amended Omnibus Incentive Plan.
The company reported strong financial performance in 2025, including record revenues, premium growth, and insurance in force, with net income before tax rising to $17.5 million.
Strategic initiatives focused on new product launches, expanded distribution, and disciplined financial management have driven two consecutive years of premium revenue growth.
Voting matters and shareholder proposals
Shareholders will elect seven directors, with three current directors retiring and one new nominee, Sean McLaughlin, up for election.
Ratification of Grant Thornton LLP as independent auditor for 2026 is recommended.
Advisory vote on executive compensation (“Say-on-Pay”) is recommended for approval.
Approval of the amended and restated Omnibus Incentive Plan, increasing available shares and adding governance enhancements, is recommended.
Board of directors and corporate governance
Six of seven director nominees are independent; the board is diverse in skills and backgrounds.
Board refreshment policies include a mandatory retirement age of 75 and a 12-year service limit.
All board committees are composed entirely of independent directors and meet regularly, with strong attendance and annual self-evaluations.
The board maintains an independent chair structure and robust governance documents, including a code of ethics and compensation recovery policy.
Latest events from Citizens
- Q1 2026 delivered 7% revenue growth, $2.3M net income, and higher book value per share.CIA
Q1 20268 May 2026 - Key votes include director elections, auditor ratification, and executive pay approval.CIA
Proxy filing30 Apr 2026 - Record 2025 revenues and insurance in force set the stage for accelerating EPS growth.CIA
Investor presentation15 Apr 2026 - Record revenues and unique white label growth position the company for continued expansion in 2026.CIA
Emerging Growth Conference 912 Apr 2026 - Record 2025 revenues and insurance in force, with strong premium growth and positive 2026 outlook.CIA
Q4 202512 Mar 2026 - Strong growth, record sales, and expanding market presence drive optimism for future performance.CIA
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - Rapid growth, global expansion, and conservative management drive strong performance.CIA
Emerging Growth Virtual Conference19 Dec 2025 - Up to 5,000,000 shares offered via a direct investment plan for long-term capital needs.CIA
Registration Filing16 Dec 2025 - Rapid growth, innovation, and balanced global expansion drive the company's forward strategy.CIA
Emerging Growth Conference 8812 Dec 2025